Full-Time
Posted on 10/30/2024
$150k - $200kAnnually
Senior
New York, NY, USA
Company Size
51-200
Company Stage
N/A
Total Funding
$16.8B
Headquarters
Greenwich, Connecticut
Founded
1999
Help us improve and share your feedback! Did you find this helpful?
Health Insurance
Dental Insurance
Performance Bonus
Meal Benefits
Hybrid Work Options
New equity funding from Portage Capital Solutions, Viking Global Investors, and PROPELR Growth underscores Valsoft's leadership and growth potential MONTRÉAL, QC / ACCESSWIRE / December 26, 2024 /Valsoft Corporation Inc. ("Valsoft"), a Canadian company ...
Metsera, Inc., a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today anno
Magenta Medical has secured $105 million in a financing round led by Novo Holdings, with participation from Viking Global Investors, RA Capital Management, and existing investors like OrbiMed and New Enterprise Associates. The funds will support US clinical programs and FDA approval pursuits for the Elevate heart pump, designed for high-risk percutaneous coronary interventions. The Elevate System, noted for its small size and high power, has received Breakthrough Device Designation from the FDA.
Israeli startup aims to compete with U.S. heart-pump pioneer Abiomed, now owned by Johnson & Johnson. But analysts say the market has lots of room to grow.
Antheia announced $17 million in new funding through a government project agreement with the Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) and matching support from new strategic investors. The funding includes a non-dilutive two-year project agreement up to $11 million from BioMaP and additional investment from In-Q-Tel, Inc. (IQT), Echo Investment Capital (Echo), and existing investors like Viking Global Investors.